Nephron Experimental Nephrology

 

Cell Adhesion Molecules in the Kidney: From Embryo to Adult

Perantoni A.O.

Author affiliations

Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Md., USA

Related Articles for ""

Exp Nephrol 1999;7:80–102

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

For eJournal Archive and eJournal Backfiles information please contact Karger service

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: April 23, 1999
Issue release date: March – April

Number of Print Pages: 23
Number of Figures: 0
Number of Tables: 6


eISSN: 1660-2129 (Online)

For additional information: https://www.karger.com/NEE

Abstract

Multiple members from every major family of cell adhesion molecules (CAMs) have been implicated in the development, maintenance, or repair of renal tissues and include several isoforms of integrins, cell-bound glycoproteins, cadherins, immunoglobulin cell adhesion molecules, and selectins. In combination, they mediate a variety of cell-basement membrane and cell-cell interactions believed to direct morphogenesis and cell migration and regulate cell growth and apoptosis, in addition to generating a functional barrier for blood filtration and helping manage inflammatory responses in the kidney. The expression of some CAMs is transient during and critical to normal nephrogenesis, varying with specific stages of development, but often ultimately resulting in the constitutive production of other members in mature tissues. While gene-targeting studies have successfully implicated individual CAMs in renal cell functions, e.g., α3β1 and α8β1 integrins, the loss of others bears no renal phenotype due to redundancy of homologous family members or to the severity of the defect early in embryogenesis. This review summarizes the studies of various CAMs found in normal embryonic or adult kidney, describes their spatiotemporal expression patterns, and discusses their involvement in renal processes.




Related Articles:


References

  1. Perantoni AO, Dove LF, Williams CL: Induction of tubules in rat metanephrogenic mesenchyme in the absence of an inductive tissue. Differentiation 1991;48:25–31.
  2. Perantoni AO, Dove LF, Karavanova I: Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc Natl Acad Sci USA 1995;92:4696–4700.
    External Resources
  3. Karavanova ID, Dove LF, Resau JH, et al: Conditioned medium from a rat ureteric bud cell line in combination with bFGF induces complete differentiation of isolated metanephric mesenchyme. Development 1996;122:4159–4167.
    External Resources
  4. Aplin AE, Howe A, Alahari SK, et al: Signal transduction and signal modulation by cell adhesion receptors: The role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 1998;50:197–263.
  5. Gulberg D, Ekblom P: Extracellular matrix and its receptors during development. Int J Dev Biol 1995;39:845–854.
  6. Faull RJ, Ginsberg MH: Inside-out signaling through integrins. J Am Soc Nephrol 1996;7:1091–1097.
  7. Kern A, Briesewitz R, Bank I, et al: The role of the I domain in ligand binding of the human integrin α1β1. J Biol Chem 1994;269:22811–22816.
    External Resources
  8. Loftus JC, Liddington RC: New insights into integrin-ligand interaction. J Clin Invest 1997;100(suppl):77–81.
  9. Yamada KM: Adhesive recognition sequences. J Biol Chem 1991;266:12809–12812.
    External Resources
  10. LaFlamme SE, Akiyama SK, Yamada KM: Regulation of fibronectin receptor distribution. J Cell Biol 1992;117:437–447.
  11. Korhonen M, Laitinen L, Ylänne J, et al: Integrins in developing, normal and malignant human kidney. Kidney Int 1992;41:641–644.
  12. Hemler ME, Sanchez-Madrid F, Flotte TJ, et al: Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: Cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol 1984;132:3011–3018.
  13. Hemler ME, Huang C, Schwarz L: The VLA protein family: Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight β subunit. J Biol Chem 1987;262:3300–3309.
  14. Kramer RH, Marks N: Identification of integrin collagen receptors on human melanoma cells. J Biol Chem 1989;264:4684–4688.
  15. Tawil NJ, Houde M, Blacher R, et al: α1β1 integrin heterodimer functions as a dual laminin/collagen receptor in neural cells. Biochemistry 1990;29:6540–6544.
    External Resources
  16. Colognato-Pyke H, O’Rear JJ, Yamada Y, et al: Mapping of network-forming, heparin-binding, and α1β1 integrin-recognition sites within the α-chain short arm of laminin-1. J Biol Chem 1995;270:9398–9406.
  17. Korhonen M, Ylanne J, Laitinen L, et al: The α1–α6 subunits of integrins are characteristically expressed in distinct segments of developing and adult human nephron. J Cell Biol 1990;111:1245–1254.
  18. Rahilly MA, Fleming S: Differential expression of integrin alpha chains by renal epithelial cells. J Pathol 1992;167:327–334.
  19. Holthäfer H, Sainio K, Miettinen A: The glomerular mesangium: Studies of its developmental origin and markers in vivo and in vitro. APMIS 1995;103:354–366.
  20. Roy-Chaudhury P, Hillis G, McDonald S, et al: Importance of the tubulointerstitium in human glomerulonephritis. II. Distribution of integrin chains β1, α1 and 6 and αv. Kidney Int 1997;52:103–110.
  21. Gardner H, Kreidberg J, Koteliansky V, et al: Deletion of integrin α1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev Biol 1996;175:301–313.
  22. Warren AP, Owens CN, Borysiewicz LK, et al: Down-regulation of integrin α11 expression and association with cell rounding in human cytomegalovirus-infected fibroblasts. J Gen Virol 1994;75:3319–3325.
  23. Kern A, Marcantoni EE: Role of the I-domain in collagen binding specificity and activation of the integrins α1β1 and α2β1. J Cell Physiol 1998;176:634–641.
  24. Schoenenberger CA, Zuk A, Zinkl GM, et al: Integrin expression and localization in normal MDCK cells and transformed MDCK cells lacking apical polarity. J Cell Sci 1994;107:527–541.
    External Resources
  25. Saelman EU, Kelely PJ, Santoro SA: Loss of MDCK cell α21 integrin expression results in reduced cyst formation, failure of hepatocyte growth factor/scatter factor-induced branching morphogenesis, and increased apoptosis. J Cell Sci 1995;108:3531–3540.
  26. Schwimmer R, Ojakian GK: The α2β1 integrin regulates collagen-mediated MDCK epithelial membrane remodeling and tubule formation. J Cell Sci 1995;108:2487–2498.
    External Resources
  27. Elices MJ, Urry LA, Hemler ME: Receptor functions for the integrin VLA-3: Fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations. J Cell Biol 1991;112:169–181.
  28. Hemler ME, Elices MJ, Chan BM, et al: Multiple ligand binding functions for VLA-2 (α2β1) and VLA-3 (α3β1) in the integrin family. Cell Differ Dev 1990;32:229–238.
  29. Dedhar S, Lewell K, Rojiani M, et al: The receptor for the basement membrane glycoprotein entactin is the integrin α31. J Biol Chem 1992;267:18908–18914.
  30. Delwel GO, de Melker AA, Hogervorst F, et al: Distinct and overlapping ligand specificities of the α3Aβ and α61 integrins: Recognition of laminin isoforms. Mol Biol Cell 1994;5:203–215.
  31. Tamura RN, Cooper HM, Collo G, et al: Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains. Proc Natl Acad Sci USA 1991;88:10183–10187.
    External Resources
  32. Symington BE, Takada Y, Carter WG: Interaction of integrins α3β1 and α2β1: Potential role in keratinocyte intercellular adhesion. J Cell Biol 1993;120:523–535.
  33. Adler S: Characterization of glomerular epithelial cell matrix receptors. Am J Pathol 1992;141:571–578.
  34. Patey N, Halbwachs-Mecarelli L, Droz D, et al: Distribution of integrin subunits in normal human kidney. Cell Adhes Commun 1994;2:159–167.
  35. Kreidberg JA, Donovan MJ, Goldstein SL, et al: Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 1996;122:3535–3547.
  36. Williams DA, Rios M, Stephens C, et al: Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 1991;352:438–441.
  37. Elices MJ, Osborn L, Takada Y, et al: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990;60:577–584.
  38. Carlos T, Kovach N, Schwartz B, et al: Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: Endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 1991;77:2266–2271.
  39. Jaspers M, Wu RR, Van der Schueren B, et al: Localization of α4m integrin at sites of mesenchyme during embryonic mouse development. Differentiation 1995;59:79–86.
  40. Sheppard AM, Onken MD, Rosen GD, et al: Expanding roles for alpha 4 integrin and its ligands in development. Cell Adhes Commun 1994;2:27–43.
  41. Guan JL, Hynes RO: Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4β1. Cell 1990;60:53–61.
  42. Mould AP, Wheldon LA, Komoriya A, et al: Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin α4β1. J Biol Chem 1990;265:4020–4024.
    External Resources
  43. Rupprecht HD, Schöcklmann HO, Sterzel RB: Cell-matrix interactions in the glomerular mesangium. Kidney Int 1996;49:1575–1582.
  44. Yang JT, Rayburn H, Hynes RO: Cell adhesion events mediated by α4 integrins are essential in placental and cardiac development. Development 1995;121:549–560.
  45. Muschler JL, Horwitz AF: Down-regulation of the chicken α5β1 integrin fibronectin receptor during development. Development 1991;113:327–337.
    External Resources
  46. Pytela R, Piershbacher MD, Ruoslahti E: Identification and isolation of a 140 kD cell surface glycoprotein with properties expected of a fibronectin receptor α4β1. Cell 1985;40:191–198.
    External Resources
  47. Goh KL, Yang JT, Hynes RO: Mesodermal defects and cranial neural crest apoptosis in α5 integrin-null embryos. Development 1997;124:4309–4319.
    External Resources
  48. Yang JT, Rayburn H, Hynes RO: Embryonic mesodermal defects in α5 integrin-deficient mice. Development 1993;119:1093–1105.
  49. Georges-Labouesse E, Messaddeq N, Yehia G, et al: Absence of integrin α6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet 1996;13:370–373.
  50. Schmidt C, Kunemund V, Wintergerst ES, et al: CD9 of mouse brain is implicated in neurite outgrowth and cell migration in vitro and is associated with the α61 integrin and the neural adhesion molecule L1. J Neurosci Res 1996;43:12–31.
  51. Hogervorst F, Admiraal LG, Niessen C, et al: Biochemical characterization and tissue distribution of the A and B variants of the integrin α6 subunit. J Cell Biol 1993;121:179–191.
  52. Sonnenberg A, Linders CJ, Daams JH, et al: The α6β1 (VLA-6) and α6β4 protein complexes: Tissue distribution and biochemical properties. J Cell Sci 1990;96:207–217.
    External Resources
  53. Falk M, Salmivirta K, Durbeej M, et al: Integrin α61 is involved in kidney tubulogenesis in vitro. J Cell Sci 1996;109:2801–2810.
    External Resources
  54. Sorokin L, Sonnenberg A, Aumailley M, et al: Recognition of the laminin E8 cell-binding site by an integrin. J Cell Biol 1990;111:1265–1273.
  55. Müller U, Wang D, Denda S, et al: Integrin α8β1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 1997;88:603–613.
  56. Bossy B, Bossy-Wetzel E, Reichardt LF: Characterization of the integrin α8 subunit: A new integrin β1-associated subunit, which is prominently expressed on axons and on cells in contact with basal laminae in chick embryos. EMBO J 1991;10:2375–2385.
    External Resources
  57. Schnapp LM, Breuss JM, Ramos DM, et al: Sequence and tissue distribution of the human integrin α8 subunit: A β1-associated α subunit expressed in smooth muscle cells. J Cell Sci 1995;108:537–544.
    External Resources
  58. Denda S, Reichardt LF, Müller U: Identification of osteopontin as a novel ligand for the integrin α8β1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 1998;9:1425–1435.
  59. Wang A, Patrone L, McDonald JA, et al: Expression of the integrin subunit α9 in the murine embryo. Dev Dyn 1995;204:421–431.
  60. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11–25.
  61. Yang JT, Hynes RO: Fibronectin receptor functions in embryonic cells deficient in α5β1 integrin can be replaced by αv integrins. Mol Biol Cell 1996;7:1737–1748.
  62. Bodary SC, McLean JW: The integrin β1 subunit associates with the vitronectin receptor αv subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem 1990;265:5938–5941.
    External Resources
  63. Hu DD, Lin EC, Kovach NL, et al: A biochemical characterization of the binding of osteopontin to integrins αvβ1 and αvβ5. J Biol Chem 1995;270:26232–26238.
  64. Vogel BE, Tarone G, Giancotti FG, et al: A novel fibronectin receptor with an unexpected subunit composition (αvβ1). J Biol Chem 1990;265:5934–5937.
    External Resources
  65. Varner JA, Brooks PC, Cheresh DA: The integrin αvβ3: Angiogenesis and apoptosis. Cell Adhes Commun 1995;3:367–374.
    External Resources
  66. Smith JW, Vestal DJ, Irwin SV, et al: Purification and functional characterization of integrin αvβ5: An adhesion receptor for vitronectin. J Biol Chem 1990;265:11008–11013.
    External Resources
  67. Busk M, Pytela R, Sheppard D: Characterization of the integrin αvβ6 as a fibronectin-binding protein. J Biol Chem 1992;267:5790–5796.
    External Resources
  68. Prieto AL, Edelman GM, Crossin KL: Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sci USA 1993;90:10154–10158.
  69. Sheppard D, Rozzo C, Starr L, et al: Complete amino acid sequence of a novel integrin β subunit. J Biol Chem 1990;265:11502–11507.
    External Resources
  70. Wada J, Kumar A, Liu Z, et al: Cloning of mouse integrin αv cDNA and role of the αv-related matrix receptors in metanephric development. J Cell Biol 1996;132:1161–1176.
  71. Humphries MJ: Integrin activation: The link between ligand binding and signal transduction. Curr Opin Cell Biol 1996;8:632–640.
  72. Korhonen M, Ylanne J, Laitinen L, et al: Distribution of β1 and β3 integrins in human fetal and adult kidney. Lab Invest 1990;62:616–625.
  73. Stephens LE, Sutherland AE, Klimanskaya IV, et al: Deletion of β1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev 1995;9:1883–1895.
  74. Fässler R, Meyer M: Consequences of lack of β1 integrin gene expression in mice. Genes Dev 1995;9:1896–1908.
  75. Yamada S, Brown KE, Yamada KM: Differential mRNA regulation of integrin subunits αv, β1, β3, and β5 during mouse embryonic organogenesis. Cell Adhes Commun 1995;3:311–325.
    External Resources
  76. Pasqualini R, Bodorova J, Ye S, et al: A study of the structure, function and distribution of β5 integrins using novel anti-β5 monoclonal antibodies. J Cell Sci 1993;105:101–111.
    External Resources
  77. Breuss JM, Gillett N, Lu L, et al: Restricted distribution of integrin β6 mRNA in primate epithelial tissues. J Histochem Cytochem 1998;41:1521–1527.
  78. Breuss JM, Gallo J, DeLisser HM, et al: Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 1995;108:2241–2251.
    External Resources
  79. Sheppard D, Cohen DS, Wang A, et al: Transforming growth factor beta differentially regulates expression of integrin subunits in guinea pig airway epithelial cells. J Biol Chem 1992;267:17409–17414.
    External Resources
  80. Huang XZ, Wu JF, Cass D, et al: Inactivation of the integrin β1 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lungs and skin. J Cell Biol 1996;133:1–8.
    External Resources
  81. Henry MD, Campbell KP: Dystroglycan: An extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol 1996;8:625–631.
  82. Campbell KP: Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage. Cell 1995;80:675–679.
  83. Carbonetto S: Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem 1993;268:14972–14978.
  84. Gesemann M, Brancaccio A, Schumacher B, et al: Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. J Biol Chem 1998;273:600–605.
  85. Rybakova IN, Amann KJ, Ervasti JM: A new model for the interaction of dystrophin with F-actin. J Cell Biol 1996;135:661–672.
  86. Matsumura K, Chiba A, Yamada H, et al: A role of dystroglycan in schwannoma cell adhesion to laminin. J Biol Chem 1997;272:13904–13910.
  87. Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O, et al: Non-muscle α-dystroglycan is involved in epithelial development. J Cell Biol 1995;130:79–91.
    External Resources
  88. Groffen AJ, Buskens CA, van Kuppevelt TH, et al: Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem 1998;254:123–128.
    External Resources
  89. Raats CJ, Bakker MA, Hoch W, et al: Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem 1998;273:17832–17838.
  90. Durbeej M, Henry MD, Ferletta M, et al: Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem 1998;46:449–457.
  91. Williamson RA, Henry MD, Daniels KJ, et al: Dystroglycan is essential for early embryonic development: Disruption of Reichert’s membrane in Dag 1-null mice. Hum Mol Genet 1997;6:831–841.
  92. Salmivirta M, Jalkanen M: Syndecan family of cell surface proteoglycans: Developmentally regulated receptors for extracellular effector molecules. Experientia 1995;51:863–872.
    External Resources
  93. Woods A, Couchman JR: Syndecans: Synergistic activators of cell adhesion. Trends Cell Biol 1998;8:189–192.
    External Resources
  94. Oh E-S, Woods A, Couchman JR: Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J Biol Chem 1997;272:11805–11811.
  95. Woods A, Couchman JR: Protein kinase C involvement in focal adhesion formation. J Cell Sci 1992;101:277–290.
    External Resources
  96. Vainio S, Lehtonen E, Jalkanen M, et al: Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol 1989;134:382–391.
    External Resources
  97. Tsuzuki S, Kojima T, Katsumi A, et al: Molecular cloning, genomic organization, promoter activity, and tissue-specific expression of the mouse ryudocan gene. J Biochem (Tokyo) 1997;122:17–24.
  98. Pyke C, Kristensen P, Ostergaard PB, et al: Proteoglycan expression in the normal rat kidney. Nephron 1997;77:461–470.
  99. Quaranta V, Plopper GE: Integrins and laminins in tissue remodeling. Kidney Int 1997;51:1441–1446.
  100. Sung U, O’Rear JJ, Yurchenco PD: Cell and heparin binding in the distal long arm of laminin: Identification of active and cryptic sites with recombinant and hybrid glycoprotein. J Cell Biol 1993;123:1255–1268.
  101. Ekblom M, Klein G, Mugrauer G, et al: Transient and locally restricted expression of laminin A chain mRNA by developing epithelial cells during kidney organogenesis. Cell 1990;60:337–346.
    External Resources
  102. Miner JH, Patton BL, Lentz SI, et al: The laminin α chains: Expression, developmental transitions, and chromosomal locations of α1–5, identification of heterotrimeric laminins 8–11, and cloning of a novel α3 isoform. J Cell Biol 1997;137:685–701.
  103. Sorokin LM, Pausch F, Durbeej M, et al: Differential expression of five laminin alpha (1–5) chains in developing and adult mouse kidney. Dev Dyn 1997;210:446–462.
  104. Virtanen I, Laitinen L, Korhonen M: Differential expression of laminin polypeptides in developing and adult human kidney. J Histochem Cytochem 1995;43:621–628.
  105. Sanes JR, Engvall E, Butkowski R, et al: Molecular heterogeneity of basal laminae: Isoforms of laminin and collagen. J Cell Biol 1990;111:1685–1699.
    External Resources
  106. Mizushima H, Miyagi Y, Kikkawa Y, et al: Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors. J Biochem 1996;120:1196–1202.
    External Resources
  107. Klein G, Langegger M, Timpl R, et al: Role of laminin A chain in the development of epithelial cell polarity. Cell 1988;55:331–341.
  108. Sorokin L, Ekblom P: Development of tubular and glomerular cells of the kidney. Kidney Int 1992;41:657–664.
  109. Ekblom P: Extracellular matrix and cell adhesion molecules in nephrogenesis. Exp Nephrol 1996;4:92–96.
  110. Noakes PG, Miner JH, Gautam M, et al: The renal glomerulus of mice lacking s-laminin/laminin β2: Nephrosis despite molecular compensation by laminin β1. Nat Genet 1995;10:400–405.
  111. Miyagoe Y, Hanaoka K, Nonaka I, et al: Laminin alpha 2 chain-null mutant mice by targeted disruption of the Lama2 gene: A new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 1997;415:33–39.
    External Resources
  112. Kuang W, Xu H, Vachon PH, et al: Disruption of the lama2 gene in embryonic stem cells: Laminin alpha 2 is necessary for sustenance of mature muscle cells. Exp Cell Res 1998;241:117–125.
    External Resources
  113. van der Rest M, Garrone R: Collagen family of proteins. FASEB J 1991;5:2814–2823.
  114. Timpl R, Wiedemann H, van Delden V, et al: A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981;120:203–211.
  115. Yurchenco PD, Schittny JC: Need. FASEB J 1990;4:1577–1590.
  116. Setty S, Kim Y, Fields GB, et al: Interactions of type IV collagen and its domains with human mesangial cells. J Biol Chem 1998;273:12244–1149.
  117. Sanes JR, Engvall E, Butkowski R, et al: Molecular heterogeneity of basal laminae: Isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 1990;111:1685–1699.
    External Resources
  118. Miner JH, Sanes JR: Collagen IV α3, α4, and α5 chains in rodent basal laminae: Sequence, distribution, association with laminins, and develomental switches. J Cell Biol 1994;127:879–891.
  119. Korhonen M, Leivo I, Kangas L, et al: Expression of type IV collagen α1(IV)–α6(IV) polypeptides in normal and developing human kidney and in renal cell carcinomas and oncocytomas. Int J Cancer 1997;72:43–49.
  120. Kurodo N, Yoshikawa N, Nakanishi K, et al: Expression of type IV collagen in the developing human kidney. Pediatr Nephrol 1998;12:554–558.
  121. Barker DF, Hostikka SL, Zhou J, et al: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990;248:1224–1227.
  122. Lemmink HH, Mochizuki T, van den Heuvel PWJ, et al: Mutations in the type IV collagen α3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 1994;3:1269–1273.
  123. Miner JH, Sanes JR: Molecular and functional defects in kidneys of mice lacking collagen α3(IV): Implications for Alport syndrome. J Cell Biol 1996;135:1403–1413.
  124. Li SW, Prockop DJ, Helminen H, et al: Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev 1995;9:2821–2830.
    External Resources
  125. Ekblom P, Lehtonen E, Saxen L, et al: Shift in collagen type as an early response to induction of the metanephric mesenchyme. J Cell Biol 1981;89:276–283.
    External Resources
  126. Daïkha-Dahmane F, Dommergues M, Narcy F, et al: Distribution and ontogenesis of tenascin in normal and cystic human fetal kidneys. Lab Invest 1995;73:547–557.
  127. Kivirikko S, Saarela J, Myers JC, et al: Distribution of type XV collagen transcripts in human tissue and their production by muscle cells and fibroblasts. Am J Pathol 1995;147:1500–1509.
  128. Saarela J, Rehn M, Oikarinen A, et al: The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol 1998;153:611–626.
  129. Sumiyoshi H, Inoguchi K, Khaleduzzaman M, et al: Ubiquitous expression of the α1(XIX) collagen gene (Col19a1) during mouse embryogenesis becomes restricted to a few tissues in the adult organism. J Biol Chem 1997;272:17104–17111.
  130. Liu X, Wu H, Byrne M, et al: A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol 1995;130:227–237.
    External Resources
  131. Liu X, Wu H, Byrne M, et al: Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci USA 1997;94:1852–1856.
  132. Andrikopoulos K, Liu X, Keene DR, et al: Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet 1995;9:31–36.
    External Resources
  133. Fassler R, Schnegelsberg PN, Dausman J, et al: Mice lacking α1 (IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci USA 1994;91:5070–5074.
    External Resources
  134. Kwan KM, Pang MK, Zhou S, et al: Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: Implications for function. J Cell Biol 1997;136:459–471.
  135. Kornblihtt AR, Pesce CG, Alonso CR, et al: The fibronectin gene as a model for splicing and transcription studies. FASEB J 1996;10:248–257.
  136. Romberger DJ: Fibronectin. Int J Biochem 1997;29:939–943.
  137. Pagani F, Zagato L, Vergani C, et al: Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J Cell Biol 1991;113:1223–1229.
  138. Laitinen L, Vartio T, Virtanen I: Cellular fibronectins are differentially expressed in human fetal and adult kidney. Lab Invest 1991;64:492–498.
  139. Dixon AJ, Burns J: Ultrastructural localisation of fibronectin in mouse kidney. J Pathol 1982;138:25–31.
    External Resources
  140. George EL, Georges-Labouesse EN, Patel-King RS, et al: Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993;119:1079–1091.
  141. Sariola H, Aufderheide E, Bernhard H, et al: Antibodies to cell surface ganglioside GG3 perturb inductive epithelial-mesenchymal interactions. Cell 1988;54:235–245.
    External Resources
  142. Zhang Z, Kundu GC, Yuan C-J, et al: Severe fibronectin deposit renal glomerular disease in mice lacking uteroglobin. Science 1997;276:1408–1412.
  143. Smith JH, Denhardt DT: Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: Induction is stable at high, but not at low, cell densities. J Cell Biochem 1987;34:13–22.
    External Resources
  144. Denhardt DT, Lopez CA, Rolle EE, et al: Osteopontin-induced modifications of cellular functions. Ann NY Acad Sci 1995;760:127–142.
  145. Oldberg A, Franzen A, Heinegard D: Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986;83:8819–8823.
  146. Rogers SA, Padanilam BJ, Hruska KA, et al: Metanephric osteopontin regulates nephrogenesis in vitro. Am J Physiol 1997;272:F469–F476.
    External Resources
  147. Padanilam BJ, Martin DR, Hammerman MR: Insulin-like growth factor I-enhanced renal expression of osteopontin following acute ischemic injury in rat. Endocrinology 1996;137:2133–2140.
  148. Nomura S, Wills AJ, Edwards DR, et al: Development expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 1988;106:441–450.
  149. Liaw L, Birk DE, Ballas CB, et al: Altered wound healing in mice lacking a functional oestopontin gene (spp 1). J Clin Invest 1998;101:1468–1478.
  150. Chiquet M: Tenascin: An extracellular matrix protein involved in morphogenesis of epithelial organs. Kidney Int 1992;41:629–631.
  151. Chiquet-Ehrismann R: Tenascins, a growing family of extracellular matrix proteins. Experientia 1995;51:853–862.
  152. Salmivirta M, Elenius K, Vainio S, et al: Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem 1991;266:7733–7739.
  153. Aufderheide E, Chiquet-Ehrismann R, Ekblom P: Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J Cell Biol 1987;105:559–608.
  154. Saga Y, Yagi T, Ikawa Y, et al: Mice develop normally without tenascin. Genes Dev 1992;6:1821–1831.
  155. Nakao N, Hiraiwa N, Yoshiki A, et al: Tenascin-C promotes healing of habu-snake venom-induced glomerulonephritis. Am J Pathol 1998;152:1237–1245.
    External Resources
  156. Felding-Habermann B, Cheresh DA: Vitronectin and its receptors. Curr Opin Cell Biol 1993;5:864–868.
  157. Seiffert D, Bordin GM, Loskutoff DJ: Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes. Histochem Cell Biol 1996;105:195–201.
    External Resources
  158. Seiffert D: Constitutive and regulated expression of vitronectin. Histol Histopathol 1997;12:787–797.
  159. Rosenblatt S, Bassuk JA, Alpers CE, et al: Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: Characterization of the binding of vitronectin to osteonectin. Biochem J 1997;324:311–319.
  160. Gautam M, Noakes PG, Moscoso L, et al: Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 1996;85:525–535.
    External Resources
  161. Sage EH, Bornstein P: Extracellular proteins that modulate cell-matrix interactions. J Biol Chem 1991;266:14831–14834.
    External Resources
  162. Iruela-Arispe ML, Liska DJ, Sage EH, et al: Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev Dyn 1993;197:40–56.
  163. Lahav J: The functions of thrombospondin and its involvement in physiology and pathophysiology. Biochim Biophys Acta 1993;1182:1–14.
  164. O’Shea KS, Dixit VM: Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 1998;107:2738–2748.
  165. Hugo C, Pichler R, Meek R, et al: Thrombospondin 1 is expressed by proliferating mesangial cells in vivo and is upregulated by PDGF and bFGF. Kidney Int 1995;48:1846–1856.
  166. Schultz-Cherry S, Murphy-Ullrich JE: Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 1993;122:923–932.
  167. Hugo C, Shankland SJ, Pichler RH, et al: Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 1998;53:302–311.
  168. Marinides GN, Suchard SJ, Monkerjee BK: Role of thrombospondin in mesangial cell growth: Possible existence of an autocrine feedback growth circuit. Kidney Int 1994;46:350–357.
  169. Tada H, Isogai S: The fibronectin production is increased by thrombospondin via activation of TGF-beta in cultured human mesangial cells. Nephron 1998;79:38–43.
  170. Barth AIM, Näthke IS, Nelson WJ: Cadherins, catenins and APC protein: Interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 1997;9:683–690.
  171. Huber O, Bierkamp C, Kemler R: Cadherins and catenins in development. Curr Opin Cell Biol 1996;8:685–691.
  172. Takeichi M: Morphogenetic roles for classic cadherins. Curr Opin Cell Biol 1995;7:619–627.
  173. Suzuki ST: Structural and functional diversity of cadherin superfamily: Are new members of cadherin superfamily involved in signal transduction pathway? J Cell Biochem 1996;61:531–542.
  174. Nagafuchi A, Shirayoshi Y, Okazaki K, et al: Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature 1987;329:341–343.
  175. Masuzaki F, Mege RM, Jaffe SH, et al: cDNAs of cell adhesion molecules of different specificity induce changes in cell shape and border formation in cultured S180 cells. J Cell Biol 1990;110:1239–1252.
    External Resources
  176. Behrens J, Mareel MM, Van Roy FM, et al: Dissecting tumor cell invasion: Epithelial cells acquired invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989;108:2435–2447.
  177. Schipper JH, Frixen UH, Behrens J, et al: E-cadherin expression in squamous cell carcinomas of head and neck: Inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991;51:6328–6337.
  178. Vestweber D, Kemler R, Ekblom P: Cell adhesion molecule uvomorulin during kidney development. Dev Biol 1985;112:213–221.
    External Resources
  179. Klein G, Langegger M, Goridis C, et al: Neural cell adhesion molecules during embryonic induction and development of the kidney. Development 1988;102:749–761.
  180. Gumbiner B, Stevenson B, Grimaldi A: The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 1988;107:1575–1587.
    External Resources
  181. Wu JC, Gregory CW, DePhilip RM: P-cadherin and E-cadherin are co-expressed in MDCK cells. Biochem Biophys Res Commun 1993;195:1329–1335.
  182. Tassin MT, Beziau A, Gubler MC, et al: Spatiotemporal expression of molecules associated with junctional complexes during the in vivo maturation of renal podocytes. Int J Dev Biol 1994;38:45–54.
  183. Larue L, Ohsugi M, Hirchenhain J, et al: E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 1994;91:8263–8267.
    External Resources
  184. Riethmacher D, Brinkmann V, Birchmeier C: A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc Natl Acad Sci USA 1995;92:855–859.
    External Resources
  185. Hatta K, Takagi S, Fujisawa H, et al: Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev Biol 1987;120:215–227.
  186. Biddlestone LR, Fleming S: Morphological evidence that A-CAM is a major intercellular adhesion molecule in human kidney. J Pathol 1991;164:9–15.
    External Resources
  187. Nouwen EJDS, van der Biest I, De Broe ME: Stage- and segment-specific expression of cell adhesion molecules N-CAM, A-CAM, and L-CAM in the kidney. Kidney Int 1993;44:147–158.
  188. Tani T, Laitinen L, Kangas L, et al: Expression of E- and N-cadherin in renal cell carcinomas, in renal cell carcinoma cell lines in vitro and in their xenografts. Int J Cancer 1995;64:407–414.
  189. Duband JL, Volberg T, Sabanay I, et al: Spatial and temporal distribution of the adherens-junction-associated adhesion molecule A-CAM during avian embryogenesis. Development 1988;103:325–344.
  190. Radice GL, Rayburn H, Matsunami H, et al: Developmental defects in mouse embryos lacking N-cadherin. Dev Biol 1997;181:64–78.
  191. Hirai Y, Nose A, Kobayashi S, et al: Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. I. Lung epithelial morphogenesis. Development 1989;105:263–270.
  192. Hirai Y, Nose A, Kobayashi S, et al: Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis. Development 1989;105:271–277.
    External Resources
  193. Radice GL, Ferreira-Cornwell MC, Robinson SD, et al: Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol 1997:139:1025–1032.
  194. Xiang Y-Y, Tanaka M, Suzuki M, et al: Isolation of complementary DNA encoding K-cadherin, a novel rat cadherin preferentially expressed in fetal kidney and kidney carcinoma. Cancer Res 1994;54:3034–3041.
    External Resources
  195. Paul R, Ewing CM, Robinson JC, et al: Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma. Cancer Res 1997;57:2741–2748.
  196. Shimoyama Y, Gotoh M, Terasaki T, et al: Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells. Cancer Res 1995;15:2206–2211.
  197. Cho EA, Patterson LT, Brookhiser WT, et al: Differential expression and function of cadherin-6 during renal epithelium development. Development 1998;125:803–812.
  198. Rosenberg P, Esni F, Sjödin A, et al: A potential role for R-cadherin in striated muscle formation. Dev Biol 1997;187:55–70.
  199. Goto S, Yaoita E, Matsunami H, et al: Involvement of R-cadherin in the early stage of glomerulogenesis. J Am Soc Nephrol 1998;9:1234–1241.
  200. Bahjaoui-Bouhaddi M, Padilla F, Nicolet M, et al: Localized deposition of M-cadherin in the glomeruli of the granular layer during the postnatal development of mouse cerebellum. J Comp Neurol 1997;378:180–195.
  201. Simonneau L, Kitagawa M, Suzuki S, et al: Cadherin 11 expression marks the mesenchymal phenotype: Toward new functions for cadherins? Cell Adhes Commun 1995;3:115–130.
    External Resources
  202. Thomson RB, Igarashi P, Biemesderfer D, et al: Isolation and cDNA cloning of Ksp-cadherin, a novel kidney-specific member of the cadherin multigene family. J Biol Chem 1995;270:17594–17601.
  203. Thomson RB, Ward DC, Quaggin SE, et al: cDNA cloning and chromosomal localization of the human and mouse isoforms of Ksp-cadherin. Genomics 1998;51:445–451.
  204. Green KJ, Jones JCR: Desmosomes and hemidesmosomes: Structures and function of molecular components. FASEB J 1996;10:871–881.
  205. Garrod D, Chidgey M, North A: Desmosomes: Differentiation, development, dynamics and disease. Curr Opin Cell Biol 1996;8:670–678.
  206. Koch PJ, Goldschmidt MD, Zimblemann R, et al: Complexity and expression patterns of the desmosomal cadherins. Proc Natl Acad Sci USA 1992;89:353–357.
    External Resources
  207. Chitaev NA, Troyanovsky SM: Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J Cell Biol 1997;14:193–201.
  208. Smith EA, Fuchs E: Defining the interactions between intermediate filaments and desmosomes. J Cell Biol 1998;141:1229–1241.
  209. Lewis JE, Wahl JK III, Sass KM, et al: Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J Cell Biol 1997;136:919–934.
  210. Lewis JE, Jensen PJ, Wheelock MJ: Cadherin function is required for human keratinocytes to assemble desmosomes and stratify in response to calcium. J Invest Dermatol 1994;102:870–877.
  211. Garrod DR, Fleming S: Early expression of desmosomal components during kidney tubule morphogenesis in human and murine embryos. Development 1990;108:313–321.
    External Resources
  212. Allen E, Yu Q-C, Fuchs E: Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 1996;133:1367–1382.
    External Resources
  213. Bierkamp C, McLaughlin KJ, Schwarz H, et al: Embryonic heart and skin defects in mice lacking plakoglobin. Dev Biol 1996;180:780–785.
  214. Ruiz P, Brinkmann V, Ledermann B, et al: Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol 1996;135:215–225.
    External Resources
  215. Roberts GA, Burdett ID, Pidley SC, et al: Antisense expression of a desmocollin gene in MDCK cells alters desmosome plaque assembly but does not affect desmoglein expression. Eur J Cell Biol 1998;76:192–203.
  216. Cunningham BA: Cell adhesion molecules as morphoregulators. Curr Opin Cell Biol 1995;7:628–633.
  217. Joseph-Silverstein J, Silverstein RL: Cell adhesion molecules: An overview. Cancer Invest 1998;16:176–182.
  218. Crossin KL, Edelman GM, Cunningham BA: Mapping of three carbohydrate attachment sites in embryonic and adult forms of the neural cell adhesion molecule. J Cell Biol 1984;99:1848–1855.
    External Resources
  219. Rothbard JB, Brackenbury R, Cunningham BA, et al: Differences in the carbohydrate structures of neural cell adhesion molecules from adult and embryonic chicken brains. J Biol Chem 1982;257:11064–11069.
    External Resources
  220. Roth J, Taatjes DJ, Bitter-Suermann D, et al: Polysialic acid units are spatially and temporally expressed in developing postnatal rat kidney. Proc Natl Acad Sci USA 1987;84:1969–1973.
    External Resources
  221. Beggs HE, Baragona SC, Hemperly JM, et al: NCAM140 interacts with the focal adhesion kinase p125(fak) and the SRC-related tyrosine kinase p59(fyn). J Biol Chem 1997;272:8310–8319.
  222. Doherty P, Walsh FS: CAM-FGF receptor interactions: A model for axonal growth. Mol Cell Neurosci 1996;8:99–111.
  223. Lackie PM, Zuber C, Roth J: Polysialic acid and N-CAM localisation in embryonic rat kidney: Mesenchymal and epithelial elements show different patterns of expression. Development 1990;110:933–947.
    External Resources
  224. Takaha N, Taira E, Tanikura H, et al: Expression of gicerin in the development, oncogenesis and regeneration of the chick kidney. Differentiation 1995;58:313–320.
  225. Vainio O, Dunon D, Aissi F, et al: HEMCAM, an adhesion molecule expressed by c-kit+ hemopoietic progenitors. J Cell Biol 1996;135:1655–1668.
    External Resources
  226. Tsukamoto Y, Matsumoto T, Taira E, et al: Adhesive activity of gicerin, a cell adhesion molecule, in kidneys and nephroblastomas of chickens. Cell Tissue Res 1998;292:137–142.
  227. Garner CM, Richards GM, Adu D, et al: Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression and function on cultured human glomerular epithelial cells. Clin Exp Immunol 1994;95:322–326.
    External Resources
  228. Matsumura R, Umemiya K, Nakazawa T, et al: Expression of cell adhesion molecules in tubulointerstitial nephritis associated with Sjögren’s syndrome. Clin Nephrol 1998;49:74–81.
  229. Wuthrich RP, Jenkins TA, Snyder TL: Regulation of cytokine-stimulated vascular cell adhesion molecule-1 expression in renal tubular epithelial cells. Transplantation 1993;55:172–177.
  230. Savage COS, Brooks CJ, Adu D, et al: Cell adhesion molecule expression within human glomerular and kidney organ culture. J Pathol 1997;181:111–115.
  231. Kwee L, Baldwin HS, Shen HM, et al: Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 1995;121:489–503.
    External Resources
  232. Slight JE Jr, Ballantyne CM, Rich SS, et al: Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1993;90:8529–8533.
  233. Bullard DC, King PD, Hicks MJ, et al: Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Gas(Ipr) mice from early lethality. J Immunol 1997;159:2058–2067.
    External Resources
  234. Kelly KJ, Willimas WW Jr, Colvin RB, et al: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996;97:1056–1063.
  235. Pasquale EB: The Eph family of receptors. Curr Opin Cell Biol 1997;9:608–615.
  236. Sefton M, Nieto MA: Multiple roles of Eph-like kinases and their ligands during development. Cell Tissue Res 1997;290:243–250.
  237. Maru Y, Hirai H, Yoshida MC, et al: Evolution, expression, and chromosomal location of a novel receptor tyrosine kinase gene, eph. Mol Cell Biol 1988;8:3770–3776.
  238. Beckmann MP, Cerretti DP, Baum P, et al: Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors. EMBO J 1994;13:3757–3762.
    External Resources
  239. Cerretti DP, Vanden Bos T, Nelson N, et al: Isolation of LERK-5: A ligand of the eph-related receptor tyrosine kinases. Mol Immunol 1995;32:1197–1205.
    External Resources
  240. Kozlosky CJ, Vanden Bos T, Park L, et al: LERK-7: A ligand of the Eph-related kinases is developmentally regulated in the brain. Cytokine 1997;9:540–549.
  241. Daniel TO, Stein E, Cerretti DP, et al: ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int 1996;57(suppl):73–81.
  242. Takahashi T, Huynh-Do U, Daniel TO: Renal microvascular assembly and repair: Power and promise of molecular definition. Kidney Int 1998;53:826–835.
  243. Bird MI, Foster MR, Priest R, et al: Selectins: Physiological and pathophysiological roles. Biochem Soc Trans 1997;25:1199–1206.
  244. Sass PM: The involvement of selectins in cell adhesion, tumor progression, and metastasis. Cancer Invest 1998;16:322–328.
  245. Brujin JA, Dinklo NJ: Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab Invest 1993;69:329–335.
  246. Segawa C, Wada T, Takaeda M, et al: In situ expression and soluble form of P-selectin in human glomerulonephritis. Kidney Int 1997;52:1054–1063.
  247. Mayadas TN, Johnson RC, Rayburn H, et al: Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993;74:541–544.
  248. Arbones ML, Ord DC, Ley K, et al: Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994;1:247–260.
  249. Labow MA, Norton CR, Rumberger JM, et al: Characterization of E-selectin-deficient mice: Demonstration of overlapping function of the endothelial selectins. Immunity 1994;1:709–720.
    External Resources
  250. Frenette PS, Mayadas TN, Rayburn H, et al: Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 1996;84:563–574.
  251. Mayadas TN, Mendrick DL, Brady HR, et al: Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. Kidney Int 1996;49:1342–1349.
  252. Rabb H, Ramirez G, Saba SR, et al: Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am J Physiol 1996;271:F408–F413.
    External Resources
  253. Subramaniam M, Saffaripour S, Van de Water L, et al: Role of endothelial selectins in wound repair. Am J Pathol 1997;150:1701–1709.
  254. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, et al: β3-integrin-deficient mice are a model for Glanzmann thrombastenia showing placental defects and reduced survival. J Clin Invest 1999;103:229–238

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: April 23, 1999
Issue release date: March – April

Number of Print Pages: 23
Number of Figures: 0
Number of Tables: 6


eISSN: 1660-2129 (Online)

For additional information: https://www.karger.com/NEE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP